Purpose
This is a phase 3 study. We are looking to test the safety and effectiveness of mRNA-1403 vaccine for Norovirus.
About Norovirus
Norovirus is an infection that can cause sudden diarrhea and vomiting (commonly referred to as acute gastroenteritis). Symptoms may also include nausea, stomach pain, headache and chills, usually lasting for 1 to 3 days. In severe cases, these symptoms can lead to dehydration, which may require hospitalization or IV fluids.
Participation Criteria
You can take part in this study if you are:
- 70+ years of age
- In good health
Participation Details
This study has 6 clinic visits and approximately 6 safety telephone calls over approximately 18 months. There are 3 study injections in the first 6 months.
You will be financially compensated for your time.
More studies:
RSVoyage Trial: A Maternal RSV Vaccine Study
Participants needed: 18 – 40
Posted: February 3, 2025
Improving Vaccine Communication
Participants needed: 18+
Posted: February 3, 2025
Evaluating possible solutions to cost-related barriers that limit uptake of recommended but unfunded vaccines
Participants needed: 18+
Posted: February 3, 2025
Phase 3 Clinical Trial of mRNA Vaccine Against Norovirus
Posted: February 3, 2025
Clinical Trial of mRNA Vaccine against Cytomegalovirus (CMV) in Youth Ages 9-15
Participants needed: 9 – 15
Posted: February 3, 2025